CBLB, Cbl proto-oncogene B, 868

N. diseases: 33; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis
0.440 GeneticVariation disease GWASCAT Overexpression of the Cytokine BAFF and Autoimmunity Risk. 28445677 2017
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis
0.440 GeneticVariation disease BEFREE Replication extended to the following polymorphisms: PKN2 (rs305217), GTF2B (rs7538427), EPHA4 (rs1517440), YTHDF3 (rs12115114), ANKFN1 (rs17758761) and PTPRM (rs4798571), which did not reach the threshold of significance in a follow-up of the first genome-wide association study (GWAS) conducted in multiple sclerosis; TMEM39A (rs1132200), which appeared as a newly identified susceptibility gene in the same study; a gene previously reaching GWAS significance in Italy, CBLB (rs9657904); IL12B (rs6887695, rs10045431), a susceptibility gene shared by diverse autoimmune diseases and, finally, another gene showing inconclusive association with multiple sclerosis, CNR1 (rs1049353). 22194214 2012
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis
0.440 AlteredExpression disease BEFREE These data link expression of FOXP3, CBLB and ITCH mRNA and CTLA-4 expression on the surface of CD4(+) CD25(high) T cell in MS. We hypothesize that this may reflect alterations in the inhibitory effect of CTLA-4 or in regulatory T cell function. 23039885 2012
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis
0.440 GeneticVariation disease BEFREE These data provide further evidence of the association of MS disease with variation within CBLB. 21037273 2011
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis
0.440 Biomarker disease BEFREE CBLB encodes a negative regulator of adaptive immune responses, and mice lacking the ortholog are prone to experimental autoimmune encephalomyelitis, the animal model of multiple sclerosis. 20453840 2010
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis
0.440 GeneticVariation disease GWASCAT Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. 20453840 2010
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis
0.440 GeneticVariation disease GWASDB Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. 20453840 2010
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis
0.440 Biomarker disease CTD_human Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. 20453840 2010
CUI: C0023467
Disease: Leukemia, Myelocytic, Acute
Leukemia, Myelocytic, Acute
0.310 GeneticVariation disease BEFREE In summary, novel mutations in c-CBL and CBL-b have been identified in human AML and may represent potential targets for novel therapeutics. 17475912 2007
CUI: C0023467
Disease: Leukemia, Myelocytic, Acute
Leukemia, Myelocytic, Acute
0.310 GeneticVariation disease LHGDN In summary, novel mutations in c-CBL and CBL-b have been identified in human AML and may represent potential targets for novel therapeutics. 17475912 2007
CUI: C0023467
Disease: Leukemia, Myelocytic, Acute
Leukemia, Myelocytic, Acute
0.310 CausalMutation disease CGI
Experimental Autoimmune Encephalomyelitis
0.300 Biomarker disease CTD_human CBLB encodes a negative regulator of adaptive immune responses, and mice lacking the ortholog are prone to experimental autoimmune encephalomyelitis, the animal model of multiple sclerosis. 20453840 2010
Multiple Sclerosis, Acute Fulminating
0.300 Biomarker disease CTD_human Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. 20453840 2010
Diabetes Mellitus, Insulin-Dependent
0.250 Biomarker disease BEFREE The interaction between UBASH3A and CBL-B may synergistically inhibit T cell function and affect risk for type 1 diabetes, as both genes have been shown to be associated with this autoimmune disease. 31659016 2019
Diabetes Mellitus, Insulin-Dependent
0.250 GeneticVariation disease BEFREE Furthermore, evidence of a statistical interaction with the known T1D susceptibility-associated CTLA4 polymorphism rs3087243 (laboratory name CT60, G>A) was reported (P<0.0001), such that the CBLB SNP rs3772534 G allele was overtransmitted to offspring with the CTLA4 rs3087243 G/G genotype. 17209142 2007
Diabetes Mellitus, Insulin-Dependent
0.250 GeneticVariation disease BEFREE One SNP in exon 12 of the CBLB gene was significantly demonstrated to be associated to T1D in a large Danish T1D family material of 480 families. 15629882 2005
Diabetes Mellitus, Insulin-Dependent
0.250 GeneticVariation disease BEFREE Evaluation of disease association by a multilocus transmission/disequilibrium test (TDT) gave a P value of 0.484 for IAN4L1 and 0.692 for CBLB, suggesting that neither gene influences susceptibility to common alleles of human type 1 diabetes in these populations. 14747305 2004
Diabetes Mellitus, Insulin-Dependent
0.250 GeneticVariation disease BEFREE Seven single-nucleotide polymorphism (SNP) markers spanning the CBLB gene were genotyped in multiplex T1D families and assessed for disease association by transmission disequilibrium testing. 14961073 2004
Diabetes Mellitus, Insulin-Dependent
0.250 SusceptibilityMutation disease RGD Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. 12118252 2002
Diabetes Mellitus, Insulin-Dependent
0.250 Biomarker disease RGD Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. 12118252 2002
CUI: C0017654
Disease: Glomerular Filtration Rate
Glomerular Filtration Rate
0.100 GeneticVariation phenotype GWASCAT A catalog of genetic loci associated with kidney function from analyses of a million individuals. 31152163 2019
CUI: C0020676
Disease: Hypothyroidism
Hypothyroidism
0.100 GeneticVariation disease GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
CUI: C0004364
Disease: Autoimmune Diseases
Autoimmune Diseases
0.090 Biomarker group BEFREE The interaction between UBASH3A and CBL-B may synergistically inhibit T cell function and affect risk for type 1 diabetes, as both genes have been shown to be associated with this autoimmune disease. 31659016 2019
CUI: C0004364
Disease: Autoimmune Diseases
Autoimmune Diseases
0.090 Biomarker group BEFREE The CBLB protein (CBL-B) is a key regulator of peripheral immune tolerance by limiting T cell activation and expansion and hence T cell-mediated autoimmunity through its ubiquitin E3-ligase activity. 25261476 2014
CUI: C0004364
Disease: Autoimmune Diseases
Autoimmune Diseases
0.090 Biomarker group BEFREE Understanding the signaling pathways regulated by Cbl-b in innate and adaptive immune cells is therefore essential for efficient manipulation of Cbl-b in emerging immunotherapies for human disorders such as autoimmune diseases, allergic inflammation, infections, and cancer. 24875217 2014